EP3768274 - COMPOSITION COMPRISING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID FOR USE IN THE TREATMENT OF OSTEOPOROSIS [Right-click to bookmark this link] | |||
Former [2021/04] | A COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY | ||
[2023/35] | Status | No opposition filed within time limit Status updated on 19.09.2024 Database last updated on 02.11.2024 | |
Former | The patent has been granted Status updated on 13.10.2023 | ||
Former | Grant of patent is intended Status updated on 08.08.2023 | ||
Former | Request for examination was made Status updated on 25.12.2020 | ||
Former | The international publication has been made Status updated on 28.09.2019 | Most recent event Tooltip | 19.09.2024 | No opposition filed within time limit | published on 23.10.2024 [2024/43] | Applicant(s) | For all designated states Epicyt Pharma AB Box 11072 40422 Göteborg / SE | [2021/04] | Inventor(s) | 01 /
FÄNDRIKS, Lars Askims Ängsväg 14 236 40 ASKIM / SE | 02 /
WALLENIUS, Ville Västra Eklanda Höjd 50 431 59 MÖLNDAL / SE | [2021/04] | Representative(s) | AWA Sweden AB Box 5117 200 71 Malmö / SE | [2023/46] |
Former [2021/04] | AWA Sweden AB P.O. Box 5117 200 71 Malmö / SE | Application number, filing date | 19770322.6 | 19.03.2019 | [2021/04] | WO2019SE50246 | Priority number, date | SE20180050304 | 19.03.2018 Original published format: SE 1850304 | [2021/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019182501 | Date: | 26.09.2019 | Language: | EN | [2019/39] | Type: | A1 Application with search report | No.: | EP3768274 | Date: | 27.01.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.09.2019 takes the place of the publication of the European patent application. | [2021/04] | Type: | B1 Patent specification | No.: | EP3768274 | Date: | 15.11.2023 | Language: | EN | [2023/46] | Search report(s) | International search report - published on: | SE | 26.09.2019 | (Supplementary) European search report - dispatched on: | EP | 03.12.2021 | Classification | IPC: | A61K31/567, A61K31/19, A61K31/593, A61K33/06, A61P19/00, A61K31/201, A61K31/575, A61K31/592, A61K45/06 | [2022/01] | CPC: |
A61K31/19 (EP);
A61K33/06 (EP,US);
A23L33/155 (US);
A23L33/16 (US);
A61K31/201 (EP,US);
A61K31/575 (EP);
A61K31/592 (EP,US);
A61K45/06 (EP);
A61P19/00 (EP);
| C-Set: |
A61K31/19, A61K2300/00 (EP);
A61K31/201, A61K2300/00 (EP);
A61K31/575, A61K2300/00 (EP);
A61K31/592, A61K2300/00 (EP); |
Former IPC [2021/04] | A61K31/567, A61K31/19, A61K31/593, A61K33/06, A61P19/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/04] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ZUSAMMENSETZUNG ENTHALTEND EINE KOMBINATION AUS GLYCOCHOLSÄURE UND BUTTERSÄURE ODER ÖLSÄURE, ZUR VERWENDUNG BEI DER BEHANDLUNG VON OSTEOPOROSE | [2023/35] | English: | COMPOSITION COMPRISING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID FOR USE IN THE TREATMENT OF OSTEOPOROSIS | [2023/35] | French: | COMPOSITION COMPRENANT UNE COMBINAISON D'ACIDE GLYCOCHOLIQUE ET D'ACIDE BUTYRIQUE OU D'ACIDE OLÉIQUE POUR LE TRAITEMENT DE L'OSTÉOPOROSE | [2023/35] |
Former [2021/04] | ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER BEHANDLUNG VON DURCH CALCIUMMANGEL VERURSACHTEN ERKRANKUNGEN | ||
Former [2021/04] | A COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY | ||
Former [2021/04] | COMPOSITION DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT D'ÉTATS PROVOQUÉS PAR UNE DÉFICIENCE EN CALCIUM | Entry into regional phase | 12.10.2020 | National basic fee paid | 12.10.2020 | Search fee paid | 12.10.2020 | Designation fee(s) paid | 12.10.2020 | Examination fee paid | Examination procedure | 12.10.2020 | Examination requested [2021/04] | 22.06.2022 | Amendment by applicant (claims and/or description) | 09.08.2023 | Communication of intention to grant the patent | 10.10.2023 | Fee for grant paid | 10.10.2023 | Fee for publishing/printing paid | 10.10.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 19.08.2024 | No opposition filed within time limit [2024/43] | Fees paid | Renewal fee | 16.03.2021 | Renewal fee patent year 03 | 28.02.2022 | Renewal fee patent year 04 | 28.02.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CZ | 15.11.2023 | HR | 15.11.2023 | RO | 15.11.2023 | RS | 15.11.2023 | SK | 15.11.2023 | SM | 15.11.2023 | GR | 16.02.2024 | IS | 15.03.2024 | [2024/36] |
Former [2024/35] | CZ | 15.11.2023 | |
HR | 15.11.2023 | ||
RO | 15.11.2023 | ||
RS | 15.11.2023 | ||
SM | 15.11.2023 | ||
GR | 16.02.2024 | ||
IS | 15.03.2024 | ||
Former [2024/33] | HR | 15.11.2023 | |
RS | 15.11.2023 | ||
SM | 15.11.2023 | ||
GR | 16.02.2024 | ||
IS | 15.03.2024 | ||
Former [2024/25] | HR | 15.11.2023 | |
RS | 15.11.2023 | ||
GR | 16.02.2024 | ||
IS | 15.03.2024 | ||
Former [2024/20] | GR | 16.02.2024 | |
IS | 15.03.2024 | Documents cited: | Search | [XYI]EP0252004 (CIBA GEIGY AG [CH]); | [XYI]US5376646 (PITTROF FOLKER [US], et al); | [XYI]EP1270007 (CHIESI FARMA SPA [IT]); | [XYI]US2014030352 (KHOPADE AJAY JAYSINGH [IN], et al); | International search | [A]US2006052305 (QUAY STEVEN C [US], et al); | [Y]US2007292493 (BRIERRE BARBARA T [US]); | [A]US2010204191 (MAKISHIMA MAKOTO [JP], et al); | by applicant | EP0252004 | US5376646 | EP1270007 | WO2013049595 | US8563053 | US2014030352 |